HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch

FDA Commissioner Marty Makary to resign, capping turbulent tenure: report

Marty Makary, M.D., is resigning as FDA commissioner Tuesday, ending a brief but tumultuous tenure marked by mounting criticism from all sides, according to reports.

By FiercePharma · May 13, 2026 · via FiercePharma
FDA Commissioner Marty Makary to resign, capping turbulent tenure: report

Image: FiercePharma

This is an aggregated industry headline. Read the full story at FiercePharma

RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.

Tags
peopleformat:headlineheadlineFiercePharma
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from People
All People →
After Makary departure, CDER chief Tracy Beth Høeg likely headed out at FDA: report
PeopleFiercePharma ↗
With the ink barely dry on outgoing commissioner Marty Makary’s resignation, another top regulator may be head…
May 18, 2026
UPDATED: After Makary departure, CDER chief Tracy Beth Høeg headed out at FDA
PeopleFierceBiotech ↗
With the ink barely dry on outgoing commissioner Marty Makary’s resignation, another top regulator is heading …
May 17, 2026
Takeda, slimming down for 'new era,' plots 4,500 layoffs in latest restructuring drive
PeopleFiercePharma ↗
Takeda's multiyear slim-down is expected to hit about 4,500 roles during the 2026 fiscal year, resulting in ab…
May 17, 2026